Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2004

Mar 1, 2004

29831_dirs_2004-03-01_1490508f-be34-4bdc-9bca-deb2c4a03b0d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2004-02-26

Reporting Person: MCKINNELL HENRY A (Director, Chairman and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2004-02-26 Common Stock A 75060 Acquired 1224147 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2004-02-27 Phantom Stock Units SSP $ A 112 Acquired Common Stock (112) Direct
2004-02-26 Employee Stock Option (right to buy) $37.15 A 525000 Acquired 2014-02-26 Common Stock (525000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 36162 Indirect
Common Stock 43857 Indirect

Footnotes

F1: The reported transaction constitutes the earn-out of Performance-Contingent Shares.

F2: This option becomes exercisable in three equal annual installments beginning on February 26, 2007.

F3: Each unit represents one phantom share of common stock.

F4: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service.